In alignment with this finding, the PKC activator bryostatin reduced the production of amyloid-β peptides and premature mortality in mouse models of Alzheimer’s Disease (Etcheberrigaray et al., 2004). Here, PRRT2 is linked to early-onset autosomal dominant Alzheimer disease.